title: [Cost-effectiveness considerations in the treatment of osteoporosis].
abstract: Osteoporotic fractures are associated with increased morbidity and mortality, and impose a huge financial burden on healthcare systems. Preventing osteoporotic fractures in the elderly therefore represents an important issue in terms of health economics. To date, the efficacy and cost-effectiveness of osteoporosis treatments have been studied extensively. In this article, the basic idea of health economic evaluation was introduced and articles of cost-effectiveness analysis for osteoporosis treatment were reviewed.
authors.forename: Kensuke
authors.initials: K
authors.lastname: Moriwaki
mesh_terms: D050071:Bone Density Conservation Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000191:economics*; D058866:Osteoporotic Fractures / Q000628:therapy; D011788:Quality of Life; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents